Specifically, mTOR acts through S6 kinase to inhibit IRS-1 (insulin receptor substrate) (Fig. 4C), leading to receptor signal resistance, including insulin resistance that contributes to type 2 diabetes (Blagosklonny, 2006a). Here, MTOR is linked to type 2 diabetes mellitus.